Torigen Pharmaceuticals of Farmington, CT, has entered into a preferred partnership agreement with VerticalVet of Cornelius, NC, to provide the VerticalVet group purchasing Organization access to Torigen.
“We are excited to partner with VerticalVet’s 2,000 veterinary hospitals nationwide,” said Ashley Kalinauskas, CEO and Co-Founder of Torigen. “We believe that Torigen’s innovative cancer therapeutics and our diagnostic partnerships can provide more affordable and accessible treatment options to companion animal cancer patients.”